hp-icon-2

Early detection and monitoring of neurodegenerative and neurodevelopmental disorders, healthy aging

hp-icon-1

Targeted approach: brain-enriched microRNA biomarkers in plasma

hp-icon-3

Collaborations with academia, medical centers, disease foundations and industry

hp-icon-4

Peer-reviewed publications, grant awards, patents

Technology

At DiamiR, we are developing an innovative technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis, enrollment of better defined participants into clinical trials, as well as disease progression and treatment monitoring.

null
We capture signatures of brain and synaptic health in the blood.
null
Our diagnostic product candidates address high unmet clinical needs.
null
Our technology is protected by a broad portfolio of issued and pending patents.
null
We present our work at scientific conferences and publish in peer-reviewed journals.

Leadership

Learn more

Advisory Board

Learn more

News